Monocyte and macrophage for expressing chemokine receptor with solid tumor directional chemotactic ability, and preparation and application thereof
A technology of chemokine receptors and monocyte-macrophages, which is applied in the field of monocytes and macrophages, can solve the problem of difficult delivery of immune cells, improve the efficiency and utilization of specific killing, and reduce non-specificity Immune to attack effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0053] In a second aspect, the present invention provides a method for preparing macrophages, comprising the steps of: constructing a lentiviral expression system containing chemokine receptor genes, and integrating the chemokine receptor genes into multiple macrophages using the lentiviral expression system. Macrophages are prepared after induced differentiation from competent stem cells or mononuclear macrophages;
[0054] Preferably, the pluripotent stem cells are firstly induced to differentiate into monocytes, and then differentiated into macrophages.
[0055] The strategy of stably expressing the receptor CCR2B, which recognizes the chemokine CCL2 secreted by solid tumor cells, in adoptive transplantation iMAC / Macrophage through a lentiviral expression system can endow the immune cells with three abilities in clinical treatment: 1. Significantly improve its The ability to chemotaxis and migrate to GBM and other solid tumors that can secrete chemokines, thereby enhancing ...
Embodiment 1
[0067] Example 1 Secretion of Chemokine CCL2 in Different Solid Tumor Cells
[0068] Analysis of data from the tumor cell database CCLE (Cancer Cell Line Encyclopedia) showed that solid tumors, including GBM, mesothelioma, and renal carcinoma, secreted higher levels of the chemokine CCL2.
[0069] Further data mining and comparison of the database, the results are as follows figure 1 As shown in A, the level of CCL2 secreted by GBM was found to be significantly higher than that of normal brain tissue.
[0070] GBM cell lines (U87MG, U251 and LN229), ovarian cancer cell lines (OVCAR8 and HO-8910) and blood mononuclear macrophages (THP1) were cultured in vitro, and ELISA experiments were performed on the above cells, and the results were as follows: figure 1 As shown in B, it can be seen that GBM cell lines (U87MG, U251 and LN229) highly express chemokine CCL2, and its expression level is significantly higher than that of ovarian cancer cell lines (OVCAR8 and HO-8910), and bloo...
Embodiment 2
[0082] Inject 1×10 subcutaneously in the ventral side of immunodeficient NSG mice 6 A U87MG cell carrying the luciferase gene. After tumor formation, inject 1×10 6 iMACs and T lymphocytes with fluorescent dyes. After 5 days, in vivo imaging of mice showed that both iMAC and T lymphocytes that did not express chemokine receptor CCR2B were concentrated in the mouse liver, and neither had the ability to migrate to the GBM site ( figure 2 ).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com